mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
0.089 |
0.8 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.8 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.8 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |